Business Context and Reporting Period
This Form 8-K Current Report was filed by Insulet Corporation on October 15, 2021. The filing addresses corporate governance changes, specifically the appointment of a new director and the retirement of a long-serving board member.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased the authorized number of directors from nine to 10.
- New Appointment: Luciana Borio, M.D., was appointed as a Class I director to fill the newly created vacancy. She will stand for election at the 2023 Annual Meeting of Stockholders.
- Director Retirement: Sally W. Crawford notified the Company of her decision to retire from the Board effective December 31, 2021, concluding 13 years of service.
Management Commentary and Risks
Management stated that Ms. Crawford's retirement did not involve any disagreement with other Board members or with management. Dr. Borio will receive cash and equity compensation pursuant to the Company's non-employee director compensation program. No specific risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify Dr. Borio's full background and potential conflicts of interest given her roles at ARCH Venture Partners and previous government service.
- Confirm the effective date of Ms. Crawford's retirement (December 31, 2021) and any transition plans for her committee roles.
- Review the Company's proxy statement filed on April 13, 2021, for details on the non-employee director compensation program applicable to Dr. Borio.
- Check for any subsequent filings regarding the election of Dr. Borio at the 2023 Annual Meeting.